N-丙基-4-溴苯甲酰胺 | 223557-19-5

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 中文名称: N-丙基-4-溴苯甲酰胺
• 中文别名: 4-溴-n-丙基苯甲酰胺
• 英文名称: 4-bromo-N-propylbenzamide
• CAS: 223557-19-5
• 化学式: C₁₀H₁₂BrNO
• mdl: MFCD01212029
• 分子量: 242.115
• InChiKey: HFHYZJDMVOCWSV-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  2.6
• 重原子数：
  13
• 可旋转键数：
  3
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.3
• 拓扑面积：
  29.1
• 氢给体数：
  1
• 氢受体数：
  1

安全信息

• 危险品标志：
  Xi
• 海关编码：
  2924299090

SDS

Material Safety Data Sheet

---

Section 1. Identification of the substance
N-Propyl 4-bromobenzamide
Product Name:
Synonyms: 4-Bromo-N-propylbenzamide

---

Section 2. Hazards identification
Harmful by inhalation, in contact with skin, and if swallowed.
H315: Causes skin irritation
H319: Causes serious eye irritation
H335: May cause respiratory irritation
P261: Avoid breathing dust/fume/gas/mist/vapours/spray
P305+P351+P338: IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses if present
and easy to do – continue rinsing
P302+P352: IF ON SKIN: Wash with soap and water
P321: Specific treatment (see on this label)
P405: Store locked up

---

Section 3. Composition/information on ingredients.
N-Propyl 4-bromobenzamide
Ingredient name:
CAS number: 223557-19-5

---

Section 4. First aid measures
Immediately wash skin with copious amounts of water for at least 15 minutes while removing
Skin contact:
contaminated clothing and shoes. If irritation persists, seek medical attention.
Eye contact: Immediately wash skin with copious amounts of water for at least 15 minutes. Assure adequate
flushing of the eyes by separating the eyelids with fingers. If irritation persists, seek medical
attention.
Inhalation: Remove to fresh air. In severe cases or if symptoms persist, seek medical attention.
Wash out mouth with copious amounts of water for at least 15 minutes. Seek medical attention.
Ingestion:

---

Section 5. Fire fighting measures
In the event of a fire involving this material, alone or in combination with other materials, use dry
powder or carbon dioxide extinguishers. Protective clothing and self-contained breathing apparatus
should be worn.

---

Section 6. Accidental release measures
Personal precautions: Wear suitable personal protective equipment which performs satisfactorily and meets local/state/national
standards.
Respiratory precaution: Wear approved mask/respirator
Hand precaution: Wear suitable gloves/gauntlets
Skin protection: Wear suitable protective clothing
Eye protection: Wear suitable eye protection
Methods for cleaning up: Mix with sand or similar inert absorbent material, sweep up and keep in a tightly closed container
for disposal. See section 12.
Environmental precautions: Do not allow material to enter drains or water courses.

---

Section 7. Handling and storage
Handling: This product should be handled only by, or under the close supervision of, those properly qualified
in the handling and use of potentially hazardous chemicals, who should take into account the fire,
health and chemical hazard data given on this sheet.
Storage: Store in closed vessels.

---

Section 8. Exposure Controls / Personal protection
Engineering Controls: Use only in a chemical fume hood.
Personal protective equipment: Wear laboratory clothing, chemical-resistant gloves and safety goggles.
General hydiene measures: Wash thoroughly after handling. Wash contaminated clothing before reuse.

---

Section 9. Physical and chemical properties
Not specified
Appearance:
Boiling point: No data
Melting point: No data
Flash point: No data
Density: No data
Molecular formula: C10H12BrNO
Molecular weight: 242.1

---

Section 10. Stability and reactivity
Conditions to avoid: Heat, flames and sparks.
Materials to avoid: Oxidizing agents.
Possible hazardous combustion products: Carbon monoxide, nitrogen oxides, hydrogen bromide.

---

Section 11. Toxicological information
No data.

---

Section 12. Ecological information
No data.

---

Section 13. Disposal consideration
Arrange disposal as special waste, by licensed disposal company, in consultation with local waste
disposal authority, in accordance with national and regional regulations.

---

Section 14. Transportation information
Non-harzardous for air and ground transportation.

---

Section 15. Regulatory information
No chemicals in this material are subject to the reporting requirements of SARA Title III, Section
302, or have known CAS numbers that exceed the threshold reporting levels established by SARA
Title III, Section 313.

---

SECTION 16 - ADDITIONAL INFORMATION
N/A

反应信息

• 作为反应物：
  描述：

  N-丙基-4-溴苯甲酰胺 在 palladium diacetate sodium hydroxide 、 三甲基氯硅烷 、 sodium cyanoborohydride 、 magnesium sulfate 、 caesium carbonate 、 R-(+)-1,1'-联萘-2,2'-双二苯膦 作用下， 以 异丙醇 、 甲苯 为溶剂， 生成 CJ-15,161
  参考文献：
  名称：

  Synthesis of the kappa-agonist CJ-15,161 via a palladium-catalyzed cross-coupling reaction

  摘要：

  据报道，合成CJ-15,161（1）的过程涉及通过分子间N-芳基化将适当功能化的二胺与前体α-氨基酸反应，或者更方便地，从相应的1,2-氨基醇通过1,2,3-恶二唑-2,2-二氧化物22进行合成。

  DOI：

  10.1039/b204844b
• 作为产物：
  描述：

  N-烯丙基-4-溴苯甲酰胺 在 aluminum (III) chloride 、 锰 、 cobalt(II) diacetate tetrahydrate 、 异丙醇 作用下， 以98%的产率得到N-丙基-4-溴苯甲酰胺
  参考文献：
  名称：

  钴催化还原转化烯烃加氢

  摘要：

  地球上丰富的金属催化剂比贵金属催化剂在成本、环境负担和化学选择性方面具有优势。给定金属中心的反应性差异是由配体场强引起的，配体场强可以通过开壳或闭壳碳中间体促进反应。在此，我们报告了一种用于钴催化烯烃还原的简单方案。我们没有使用需要化学计量氢化物的氧化周转机制，而是找到了需要化学计量质子的还原周转机制。反应机理似乎涉及末端烯烃的配位和氢化钴化。

  DOI：

  10.1016/j.tetlet.2021.153047

文献信息

• Alpha-helical mimetics
  申请人：Lessene Guillaume Laurent

  公开号：US20080153802A1

  公开（公告）日：2008-06-26

  Benzoyl urea derivatives that are alpha helical peptides mimetics that mimic BH3-only proteins, compositions containing them, their conjugation to cell-targeting-moieties, and their use in the regulation of cell death are disclosed. The benzoyl urea derivatives are capable of binding to and neutralizing pro-survival Bcl-2 proteins. Use of benzoyl urea derivatives in the treatment and/or prophylaxis of diseases or conditions associated with deregulation of cell death are also described.

  公开了模拟α螺旋肽的苯甲酰脲衍生物，这些衍生物模拟BH3-仅蛋白，含有它们的组合物，它们与细胞靶向基团的结合，以及它们在调节细胞死亡中的用途。苯甲酰脲衍生物能够结合并中和促生存的Bcl-2蛋白。还描述了在治疗和/或预防与细胞死亡失调相关的疾病或症状中使用苯甲酰脲衍生物。
• [EN] SUBSTITUTED 3- AND 4- AMINOMETHYLPIPERIDINES FOR USE AS BETA-SECRETASE IN THE TREATMENT OF ALZHEIMER'S DISEASE<br/>[FR] 3- ET 4- AMINOMETHYLPIPERIDINES SUBSTITUEES UTILISEES COMME BETA-SECRETASE DANS LE TRAITEMENT DE LA MALADIE D'ALZHEIMER
  申请人：ACTELION PHARMACEUTICALS LTD

  公开号：WO2004002483A1

  公开（公告）日：2004-01-08

  The invention relates to novel compounds, which are substituted chiral or achiral derivatives of 3- or 4- aminomethylpiperidine of the general formula (I). The invention also concerns related aspects including processes for the preparation of the compounds, pharmaceutical compositions containing one or more compounds of general formula (I) and especially their use as inhibitors of beta-secretases for the treatment of Alzheimer’s disease.

  本发明涉及新型化合物，其为通式（I）的3-或4-氨基甲基哌啶的取代手性或非手性衍生物。本发明还涉及包括制备这些化合物的工艺、含有一种或多种通式（I）化合物的药物组合物以及特别是它们作为β-分泌酶抑制剂用于治疗阿尔茨海默病的相关方面。
• Rhodium(III)‐Catalyzed Redox‐Neutral Coupling of α‐Trifluoromethylacrylic Acid with Benzamides through Directed C−H Bond Cleavage
  作者：Risa Yoshimoto、Yoshinosuke Usuki、Tetsuya Satoh

  DOI：10.1002/asia.201901776

  日期：2020.3.16

  A rhodium(III)-catalyzed redox-neutral coupling of α-trifluoromethylacrylic acid with bezamides proceeds smoothly accompanied by amide-directed C-H bond cleavage to produce β-[2-(aminocarbonyl)phenyl]-α-trifluoromethylpropanoic acid derivatives. One of the products can be transformed to a trifluoromethyl substituted heterocyclic compound. In addition, the redox-neutral coupling of α-trifluoromethylacrylic

  铑（III）催化的α-三氟甲基丙烯酸与苯甲酰胺的氧化还原-中性偶合顺利进行，同时酰胺定向的CH键断裂，生成β-[2-（氨基羰基）苯基]-α-三氟甲基丙酸衍生物。产物之一可以转化为三氟甲基取代的杂环化合物。另外，α-三氟甲基丙烯酸与具有含氮定向基团的相关芳族底物的氧化还原-中性偶联也可以在类似条件下进行。
• Synthesis of CF₃-Containing Isoindolinone Derivatives through Rhodium-catalyzed Oxidative Coupling of Benzamides with 2-Trifluoromethylacrylate
  作者：Risa Yoshimoto、Hideaki Morisaka、Yoshinosuke Usuki、Yu Shibata、Ken Tanaka、Tetsuya Satoh

  DOI：10.1246/cl.200609

  日期：2020.12.5

  The oxidative coupling of benzamides with methyl 2-trifluoromethylacrylate proceeds smoothly under rhodium(III) catalysis to produce trifluoromethyl-substituted isoindolinone derivatives. The catal...

  苯甲酰胺与 2-三氟甲基丙烯酸甲酯的氧化偶联在铑 (III) 催化下顺利进行，生成三氟甲基取代的异吲哚啉酮衍生物。催化剂...
• Structure-Guided Development of Potent Benzoylurea Inhibitors of BCL-X_L and BCL-2
  作者：Michael J. Roy、Amelia Vom、Toru Okamoto、Brian J. Smith、Richard W. Birkinshaw、Hong Yang、Houda Abdo、Christine. A. White、David Segal、David C. S. Huang、Jonathan B. Baell、Peter M. Colman、Peter E. Czabotar、Guillaume Lessene

  DOI：10.1021/acs.jmedchem.0c01771

  日期：2021.5.13

  Here, we outline the crystallography-guided development of a structurally distinct series of BCL-XL/BCL-2 inhibitors based on a benzoylurea scaffold, originally proposed as α-helix mimetics. We describe structure-guided exploration of a cryptic “p5” pocket identified in BCL-XL. This work yields novel inhibitors with submicromolar binding, with marked selectivity toward BCL-XL. Extension into the hydrophobic

  的BCL-2家族蛋白（包括促存活蛋白BCL-2，BCL-X大号和MCL-1）是用于新型抗癌治疗剂的发展的一个重要目标。尽管靶向小分子蛋白质相互作用的挑战，但许多抑制剂（称为BH3模拟物）已进入临床，并且BCL-2抑制剂ABT-199 / venetoclax已经证明具有转化性。对于BCL-X大号，新的验证化工系列是可取的。在这里，我们勾勒出一个结构不同的系列BCL-X的结晶学引导发展大号基于一个苯甲酰脲支架/ BCL-2抑制剂，最初提出如α螺旋模拟物。我们描述了在BCL-X L中识别出的隐秘“ p5”口袋的结构指导探索。这项工作产生了具有亚微摩尔的结合，与朝向BCL-X标记选择性新型抑制剂大号。延伸到疏水P2口袋产生最有效的抑制剂在系列，强烈结合BCL-X大号和BCL-2（纳摩尔范围的半最大抑制浓度（IC 50在工程改造到细胞）），并显示基于机制的杀伤依靠BCL-X L生存。